Cargando…

Romosozumab for osteoporosis

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236877/
https://www.ncbi.nlm.nih.gov/pubmed/34211250
http://dx.doi.org/10.18773/austprescr.2021.021
_version_ 1783714636443418624
collection PubMed
description
format Online
Article
Text
id pubmed-8236877
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-82368772021-06-30 Romosozumab for osteoporosis Aust Prescr New Drugs NPS MedicineWise 2021-04-20 2021-06 /pmc/articles/PMC8236877/ /pubmed/34211250 http://dx.doi.org/10.18773/austprescr.2021.021 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Romosozumab for osteoporosis
title Romosozumab for osteoporosis
title_full Romosozumab for osteoporosis
title_fullStr Romosozumab for osteoporosis
title_full_unstemmed Romosozumab for osteoporosis
title_short Romosozumab for osteoporosis
title_sort romosozumab for osteoporosis
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236877/
https://www.ncbi.nlm.nih.gov/pubmed/34211250
http://dx.doi.org/10.18773/austprescr.2021.021